About
Trevena, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders, including FDA-approved acute pain treatment OLINVYK® and investigational drugs for diabetic neuropathic pain, epilepsy, migraine, and opioid use disorder.
Explore Trevena's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.